Healthy Patients
Antimicrobial resistance (AMR)
AMR develops when bacteria, fungi or viruses are exposed to antibiotics, antifungals or antivirals. As a result, the antimicrobials become ineffective and infections may persist. In addition, medical interventions including surgery, chemotherapy and stem cell therapy may become impossible.
AMR is considered the biggest global threat of Health and Food Safety.
AMR Insights
For Healthcare professionals who wish to prevent Antimicrobial resistance, AMR Insights offers selected, global information and data, specific education and extensive networking and partnering opportunities.
AMR Insights is for:
- Medical Microbiologists, Infectiologists and other specialists
- General Practitioners, Pharmacists
- Infection Prevention Experts and nurses
- Medical Docters and Caretakers in nursing homes
- Managers and Labtechnicians of Microbiological Laboratories.
Latest Topics
-
04 June 2025Vaccination to preventantimicrobial resistance
The value of vaccination in preventing drug-resistant infections (AMR) is both direct and indirect. The benefits of vaccination have been quantified through modelling, but more empirical evidence is needed to validate these analyses. Wellcome launched a call for proposals in 2019 to generate additional evidence on the impact of vaccination on AMR, funding 13 projects […]
Read more... -
02 June 2025Systems thinking to understand the complexity of antimicrobial resistance across One Health: A systematic review of current approaches
Antimicrobial resistance (AMR) is a global threat affecting human health, animals, and the environment. It’s driven by interconnected factors across various domains of One Health. A systematic literature review highlights the need for systems thinking to address AMR, highlighting the need for interventions beyond antibiotic use. A multifaceted approach, including stronger regulations, increased awareness, non-antimicrobial […]
Read more... -
02 June 2025Keeping our feet on the ground: the role of innovation in scaling up diagnosis to counter antimicrobial resistance
At the UN General Assembly High-Level Meeting on antimicrobial resistance (AMR), member states committed to improving access to diagnosis and care for at least 80% of countries by 2030. However, access to quality-assured microbiology laboratories is scarce in many countries in sub-Saharan Africa, south Asia, and the Middle East, particularly in the least-resourced tiers of […]
Read more...
More news related to Healthy patients
